From Brexit to TRexit: Transperineal biopsies pose a challenge to the traditional transrectal biopsy method

By now most of us are familiar with Brexit, the UK’s pending divorce with the European Union. But in a play on that term, British doctors are also moving towards an exit they’ve dubbed “TRexit” from the most common sort of prostate biopsy: the transrectal ultrasound guided biopsy, or TRUS. Men who test positive on the PSA cancer screening test will usually have a prostate biopsy that’s performed in either of two ways. With a TRUS, doctors guided by an ultrasound machine can sample the prostate using a biopsy needle inserted through the rectum. Alternatively, the biopsy needle can be inserted (also under ultrasound guidance) through the perineum, the patch of skin located between the anus and the scrotum. Since it’s traditionally been easier to perform, and

From http://besthealthnews.com/2019/07/from-brexit-to-trexit-transperineal-biopsies-pose-a-challenge-to-the-traditional-transrectal-biopsy-method/?utm_source=rss&utm_medium=rss&utm_campaign=from-brexit-to-trexit-transperineal-biopsies-pose-a-challenge-to-the-traditional-transrectal-biopsy-method

from
https://healthnews010.wordpress.com/2019/07/27/from-brexit-to-trexit-transperineal-biopsies-pose-a-challenge-to-the-traditional-transrectal-biopsy-method/

From https://jamesjohnson10.blogspot.com/2019/07/from-brexit-to-trexit-transperineal.html

from
https://jamesjohnson10.wordpress.com/2019/07/27/from-brexit-to-trexit-transperineal-biopsies-pose-a-challenge-to-the-traditional-transrectal-biopsy-method/